Skip to content

News

First closing of our most recent €60M fund

Eleven Fund III, our third fund as the name suggests, is officially up and running as of October. Most of the private investors are already onboard and we plan to have our final closing by year end.
Read More

Our Investment in BeMe

Healthcare has the reputation of being a very conservative field, which despite its legacy is currently becoming more and more open to new technologies and innovation. This is slowly but steadily leading to a technological revolution similar to what happened in fintech a couple of years ago.
Read More

Rock music, tractors, venture capital, and more! Meet Valeri Petrov!

You might have seen some of Eleven’s Partners in interviews, read their articles, met them during events and conferences but we think it’s time to introduce them from a slightly different angle. This is why we are excited to give an official start to our “14 Questions With” blog post series, which willintroduce the more personal and little-known side of the Partners at Eleven.
Read More

Windsurfing, beer brewing, and daydreaming. Meet Ivaylo Simov!

You might have seen some of Eleven’s Partners in interviews, read their articles, met them during events and conferences but we think it’s time to introduce them from a slightly different angle. This is why we are excited to give an official start to our “14 Questions With” blog post series, which will introduce the more personal and little-known side of the Partners at Eleven.
Read More

Our investment in ProductLead

ProductLead empowers retailers to create social media ads at scale by using user generated content together with platform automation and then deploys these newly created ads directly into the social media business manager. We particularly like how ProductLead combines the best of both worlds. They have user generated content mixed with ML and creatives automation, which is then automatically plugged into your Instagram campaigns.
Read More

Eleven invests in the Greek biotech company BIOPIX-T

BIOPIX-T offers portable molecular devices for diagnostication of Covid-19, Influenza and other infectious diseases using the method of Loop-mediated isothermal amplification - (LAMP). The first product of BIOPIX-T is called Pebble. It's a portable device plus a testing kit that can perform a swab test for Covid-19 and display the results within less than 30 minutes.
Read More

Keep up with us

Receive bite-sized updates on Eleven, portfolio news, thoughts from the team and more

    Play Video